Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹946.75up ₹22.95 (2.48%)BSE ₹946.65
Share price at the NSE close on 2 Nov 2026. Previous close ₹923.80.
2 Nov: open ₹925.00, high ₹949.90, low ₹919.00
52-week range of traded prices to 2 Nov 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Next results date: the board meets on 13 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,080 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.83
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 36.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.13
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.53%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,48,07658.1% delivered
Jubilant Pharmova share news and announcements
1,153 announcements, routine notices left out, newest first. Page 18 of 24.
May 2013
8 May · Dividend
Board of Directors of the Company at its meeting held on May 07, 2013 has recommended a dividend of Rs. 3 (Rupees Three) per share of Re. 1/- each. The dividend, if approved, by the Members at the Annual General Meeting, will be paid / dispatched on or before September 26, 2013.
Apr 2013
15 Apr · Management
As per the Corporate Governance Voluntary Guidelines adopted by the Company, the Board had fixed a tenure of 9 years for Independent Directors. Accordingly, Dr Naresh Trehan and Mr Surendra Singh who have completed 9 years tenure have submitted their resignations.Dr Naresh Trehan has ceased to be director with effect from April 12, 2013 and Mr Surendra Singh has ceased to be director with effect April 15, 2013.8 Apr · Management
As per the Corporate Governance Voluntary Guidelines adopted by the Company, the Board had fixed a tenure of 9 years for Independent Directors. Accordingly, Mr. Hamidulla K. Khan, who has completed 9 years tenure has submitted his resignation. He has ceased to be director of the Company with effect from April 04, 2013.
Mar 2013
Feb 2013
27 Feb · Business
Jan 2013
21 Jan · Board meeting
To inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2012.
Dec 2012
6 Dec · Disclosure
Compensation Committee of the Board of Directors have on December 05, 2012, granted 8,84,190 (Eight Lacs Eighty Four Thousand One Hundred Ninety) Options to eligible employees and Independent Directors of the Company, in accordance with JLL Employees Stock Option Plan, 2011. Each option shall entitle the holder to acquire 1 equity share of Re. 1 of the Company at a price of Rs. 220.90 per share. Since Jubilant Employees Welfare Trust is holding sufficient number of equity shares of the Company, it is envisaged to transfer the Shares from the Trust to beneficiaries upon exercise. As such, there would be no fresh issue of Shares by the Company and hence no dilution.
Nov 2012
Oct 2012
26 Oct · Board meeting
To inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2012.
Sep 2012
Aug 2012
29 Aug · Disclosure of Voting Pattern - Clause 35A
1 Aug · Meeting
Annual General Meeting of the Company will be held on August 28, 2012. The Register of Members Share Transfer Books of the Company will remain closed from August 17, 2012 to August 28, 2012 (both days inclusive) for the purpose of Annual General Meeting and declaration of dividend, subject to the approval of members in the AGM. The dividend on equity shares @ Rs. 3 per equity share of Rs. 1 each, as recommended by the Board of Directors at its meeting held on May 07, 2012, if declared at the AGM will be paid on or before September 27, 2012.
Jul 2012
23 Jul · Management
Mr. Suresh Kumar has been appointed as Additional Director of the Company with effect from July 23, 2012.23 Jul · Disclosure
At a Meeting of the Compensation Committee of the Board of Directors held on July 23, 2012, 34,161 (Thirty Four Thousand One Hundred Sixty One) Options have been granted to eligible employees, in accordance with JLL Employees Stock Option Plan, 2011. Each option shall entitle the holder to acquire 1 equity share of Re. 1 of the Company at a price of Rs 170.20 per share. Since Jubilant Employees Welfare Trust is holding sufficient number of equity shares of the Company, it is envisaged to transfer the Shares from the Trust to beneficiaries upon exercise. As such, there would be no fresh issue of Shares by the Company and hence no dilution.13 Jul · Board meeting
To inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2012.
May 2012
7 May · Dividend
Board of Directors of the Company at its meeting held on May 07, 2012, has recommended a dividend of Rs. 3 (Rupees Three) per share of Re. 1 /- each. The dividend, if approved, by the Members at the Annual General Meeting, will be paid/despatched on or before September 27, 2012.
Apr 2012
27 Apr · Board meeting
To inter-alia consider : (1) Audited Financial Results of the Company for the year ended March 31, 2012; (2) Recommendation of Dividend for the Year ended March 31, 2012.
Feb 2012
6 Feb · Disclosure
At a Meeting of the Compensation Committee of the Board of Directors held on February 06, 2012, 28,922 (Twenty Eight Thousand Nine Hundred and Twenty Two) Options have been granted to eligible employees, in accordance with JLL Employees Stock Option Plan, 2011. Each option shall entitle the holder to acquire 1 equity share of Re. 1 of the Company at a price of Rs 174.90 per share. Since Jubilant Employees Welfare Trust is holding sufficient number of equity shares of the Company, it is envisaged to transfer the Shares from the Trust to beneficiaries upon exercise. As such, there would be no fresh issue of Shares by the Company and hence no dilution.
Jan 2012
27 Jan · Board meeting
To inter-alia consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2011.
Dec 2011
Nov 2011